Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment

The first participant has completed initial study activities and is now randomised to one of the trial’s arms.

A photograph of the chief investigator and research nurses for the LEGEND-D trial © OCDEM
LEGEND-D clinical site research team

The LEGEND-D trial aims to find ways to prevent low blood sugar levels (hypoglycaemia) in type 1 diabetes. It will use  oral diabetic medications, which are normally used to treat type 2 diabetes, in people with type 1 diabetes. Researchers will find out whether administering these medications at smaller doses than normally prescribed could help prevent hypoglycaemia. We will recruit 20 participants with type 1 diabetes and 10 participants without diabetes.

If you are interested in taking part in this trial and wish to know more, please contact the research team at legend-d@ocdem.ox.ac.uk or cru@ocdem.ox.ac.uk.

Similar stories

Professor Leanne Hodson receives Physiological Society Prize Lecture

The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.

Professor Rajesh Thakker receives prestigious William F. Neuman Award

Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.

People living with type 1 diabetes discuss project with researchers

Heavier drinking linked to higher levels of harmful “hidden” fat, study finds

A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.

Why the body stops protecting itself against low blood sugar

New RDM research reveals how prior hypoglycaemia weakens a key hormonal defence.

Night-time changes in metabolism may be driving common liver disease

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.

Similar stories

Professor Leanne Hodson receives Physiological Society Prize Lecture

The Joan Mott Prize Lecture celebrates women in physiology whose work has demonstrated impact.

Professor Rajesh Thakker receives prestigious William F. Neuman Award

Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.

People living with type 1 diabetes discuss project with researchers

Heavier drinking linked to higher levels of harmful “hidden” fat, study finds

A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.

Why the body stops protecting itself against low blood sugar

New RDM research reveals how prior hypoglycaemia weakens a key hormonal defence.

Night-time changes in metabolism may be driving common liver disease

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.